Current recommendations support the use of effective prophylactic measures to prevent venous thromboembolism and fatal pulmonary embolism in high-risk medical and surgical patients.
Answers are grounded in this paper and cite their sources.
Reinforces VTE prophylaxis per current guidelines in high-risk patients; confirms consensus but leaves optimal strategies open for prospective trials.
Pulmonary embolism remains a major cause of death in high-risk medical and surgical patients. This is unfor tunate as effective measures for prevention of venous throm boembolism in such patients are now available. Based on Level 1 evidence from clincial trials and systematic reviews, recom mendations can be made for the prevention of venous throm boembolism in most situations. If such information is not avail able, recommendations based on extrapolation from similar risk situations or from consensus opinions must be used. Additional clinical trials are required to fill in such gaps in our knowledge and permit adequate protection against fatal pulmonary embo lism in most if not all medical and surgical patients.
No takes yet. Share an insight, caveat, or question.
Hull et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: